Literature DB >> 10678978

Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

J R Johnson1, A L Stell, F Scheutz, T T O'Bryan, T A Russo, U B Carlino, C Fasching, J Kavle, L Van Dijk, W Gaastra.   

Abstract

Polymorphisms in PapA, the major structural subunit and antigenic determinant of P fimbriae of extraintestinal pathogenic Escherichia coli, are of considerable epidemiological, phylogenetic, and immunotherapeutic importance. However, to date, no method other than DNA sequencing has been generally available for their detection. In the present study, we developed and rigorously validated a novel PCR-based assay for the 11 recognized variants of papA and then used the new assay to assess the prevalence, phylogenetic distribution, and bacteriological associations of the papA alleles among 75 E. coli isolates from patients with urosepsis. In comparison with conventional F serotyping, the assay was extremely sensitive and specific, evidence that papA sequences are highly conserved within each of the traditionally recognized F serotypes despite the diversity observed among F types. In certain strains, the assay detected serologically occult copies of papA, of which some were shown to represent false-negative serological results and others were shown to represent the presence of nonfunctional pap fragments. Among the urosepsis isolates, the assay revealed considerable segregation of papA alleles according to O:K:H serotype, consistent with vertical transmission within clones, but with exceptions which strongly suggested horizontal transfer of papA alleles between lineages. Sequencing of papA from two strains that were papA positive by probe and PCR but F negative in the new PCR assay led to the discovery of two novel papA variants, one of which was actually more prevalent among the urosepsis isolates than were several of the known papA alleles. These findings provide novel insights into the papA alleles of extraintestinal pathogenic E. coli and indicate that the F PCR assay represents a versatile new molecular tool for epidemiological and phylogenetic investigations which should make rapid, specific detection of papA alleles available to any laboratory with PCR capability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678978      PMCID: PMC97319          DOI: 10.1128/IAI.68.3.1587-1599.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  92 in total

1.  Monoclonal antibodies that recognize the P fimbriae F71, F72, F9, and F11 from uropathogenic Escherichia coli.

Authors:  J M de Ree; P Schwillens; J F van den Bosch
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

2.  P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patients' characteristics.

Authors:  J R Johnson; P L Roberts; W E Stamm
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

3.  Demonstration by immuno-electronmicroscopy of antigenic heterogeneity among P fimbriae of strains of Escherichia coli.

Authors:  D C Old; D E Yakubu; P B Crichton
Journal:  J Med Microbiol       Date:  1987-05       Impact factor: 2.472

4.  Functional relationship among the gene clusters encoding F7(1), F7(2), F9, and F11 fimbriae of human uropathogenic Escherichia coli.

Authors:  I Van Die; I Van Megen; E Zuidweg; W Hoekstra; H De Ree; H Van den Bosch; H Bergmans
Journal:  J Bacteriol       Date:  1986-07       Impact factor: 3.490

5.  Analysis of P fimbriae on Escherichia coli O2, O4, and O6 strains by immunoprecipitation.

Authors:  A Pere; V Väisänen-Rhen; M Rhen; J Tenhunen; T K Korhonen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

6.  Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis.

Authors:  T K Korhonen; M V Valtonen; J Parkkinen; V Väisänen-Rhen; J Finne; F Orskov; I Orskov; S B Svenson; P H Mäkelä
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

Review 7.  Fimbrial adhesions of Escherichia coli.

Authors:  P Klemm
Journal:  Rev Infect Dis       Date:  1985 May-Jun

8.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Authors:  E A Emini; J V Hughes; D S Perlow; J Boger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis.

Authors:  R K Selander; T K Korhonen; V Väisänen-Rhen; P H Williams; P E Pattison; D A Caugant
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

10.  Monoclonal antibodies for serotyping the P fimbriae of uropathogenic Escherichia coli.

Authors:  J M de Ree; P Schwillens; J F van den Bosch
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

View more
  37 in total

1.  Detection of the Escherichia coli group 2 polysaccharide capsule synthesis Gene kpsM by a rapid and specific PCR-based assay.

Authors:  James R Johnson; Timothy T O'Bryan
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Occurrence of Clinically Important Lineages, Including the Sequence Type 131 C1-M27 Subclone, among Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Wastewater.

Authors:  Ryota Gomi; Tomonari Matsuda; Yasufumi Matsumura; Masaki Yamamoto; Michio Tanaka; Satoshi Ichiyama; Minoru Yoneda
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection.

Authors:  James R Johnson; Flemming Scheutz; Peter Ulleryd; Michael A Kuskowski; Timothy T O'Bryan; Torsten Sandberg
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.

Authors:  Bente Olesen; Flemming Scheutz; Megan Menard; Marianne N Skov; Hans Jørn Kolmos; Michael A Kuskowski; James R Johnson
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

5.  Presence and characterization of extraintestinal pathogenic Escherichia coli virulence genes in F165-positive E. coli strains isolated from diseased calves and pigs.

Authors:  Hojabr Dezfulian; Isabelle Batisson; John M Fairbrother; Peter C K Lau; Atef Nassar; George Szatmari; Josée Harel
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Novel type of fimbriae encoded by the large plasmid of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H(-).

Authors:  W Brunder; A S Khan; J Hacker; H Karch
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases.

Authors:  Johann D D Pitout; Kevin B Laupland; Deirdre L Church; Megan L Menard; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Representational difference analysis between Afa/Dr diffusely adhering Escherichia coli and nonpathogenic E. coli K-12.

Authors:  Anne-Beatrice Blanc-Potard; Colin Tinsley; Isabel Scaletsky; Chantal Le Bouguenec; Julie Guignot; Alain L Servin; Xavier Nassif; Marie-Francoise Bernet-Camard
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens.

Authors:  Timothy J Johnson; Yvonne Wannemuehler; Sara J Johnson; Adam L Stell; Curt Doetkott; James R Johnson; Kwang S Kim; Lodewijk Spanjaard; Lisa K Nolan
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

10.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.